Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Colinz Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:531210 P/E (TTM) :39.6
ISIN Demat:INE923C01011 Div & Yield %:0 EPS (TTM) :1.01
Book Value (RS) :26.0966966 Market Cap (Rs Cr.):18.28 Face Value (RS) :10
    Change Company 
YearsMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Debt-Equity Ratio0.070.050.050.100.10
Long Term Debt-Equity Ratio0.000.000.000.000.00
Current Ratio3.713.683.542.922.80
Fixed Assets1.041.141.091.010.91
Inventory8.017.857.656.394.19
Debtors8.597.076.115.554.42
Interest Cover Ratio16.5017.2513.007.003.78
PBIDTM (%)12.1011.6610.9110.908.60
PBITM (%)10.119.829.098.035.52
PBDTM (%)11.4911.1010.219.767.14
CPM (%)9.658.828.257.756.49
APATM (%)7.666.976.434.883.41
ROCE (%)6.727.707.826.784.36
RONW (%)5.435.735.814.542.97

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)